Is a 503B product FDA-approved?

No. 503B facilities are FDA-registered and inspected and must follow current good manufacturing practice, but their products are still compounded, not approved.

Which is better for a GLP-1?

Neither category guarantees quality. 503B brings federal manufacturing standards and inspection; 503A brings patient-specific preparation under state oversight. What matters is that you can identify the pharmacy and check its record.

Published August 27, 2026 · updated August 27, 2026 · medically reviewed by Dr. S. Shuwart, MD on August 27, 2026

Medically reviewed · August 27, 2026

503A vs 503B pharmacies: what the difference means for your vial

The two legal categories of compounder under the Federal Food, Drug, and Cosmetic Act, who oversees each, what each may do, and how to tell which one made your medication.

Section 503A: traditional compounding pharmacies

A 503A pharmacy compounds a drug for an identified individual patient on a valid prescription, or in limited anticipatory quantities. It is licensed and primarily overseen by its state board of pharmacy and is expected to follow United States Pharmacopeia standards for sterile and non-sterile compounding. It is not required to register with FDA, follow current good manufacturing practice, or report adverse events to FDA. Its prescriptions may not be essentially copies of a commercially available approved drug except in defined circumstances, such as a shortage or a prescriber-determined change that makes a significant difference for the patient.

Section 503B: outsourcing facilities

Created by the Drug Quality and Security Act of 2013 after a fatal outbreak linked to a compounding pharmacy, a 503B outsourcing facility registers with FDA, is inspected by FDA on a risk-based schedule, follows current good manufacturing practice, reports adverse events, and may compound in bulk without patient-specific prescriptions. It may compound from a bulk drug substance only if that substance is on FDA’s list for 503B use or the drug is on the shortage list, and the copy restriction applies here too, with its own exceptions. FDA publishes the list of registered outsourcing facilities.

What each means for a telehealth patient

Traceability. With a 503A pharmacy, your name is on the prescription and the vial. With a 503B facility, the provider may hold stock compounded in bulk and dispense to you; the facility name should still appear on the label.
Oversight. 503B is federal manufacturing oversight; 503A is state oversight of pharmacy practice. Either can produce a good or a bad product; the public record (inspections, warning letters, board actions) is what tells you which.
Availability after a shortage ends. The exceptions differ, and the enforcement dates differed for the two categories when the tirzepatide and semaglutide shortages were declared resolved. See the legal status pages.

How to tell which made yours

Ask the provider for the pharmacy’s name, then look for it on FDA’s registered outsourcing facilities list (503B) or on its state board’s licence lookup (503A). The verification guide walks through both. This site records the type for every pharmacy a provider names, and marks it unknown until we have checked.

Questions this page answers

Is a 503B product FDA-approved?: No. 503B facilities are FDA-registered and inspected and must follow current good manufacturing practice, but their products are still compounded, not approved.
Which is better for a GLP-1?: Neither category guarantees quality. 503B brings federal manufacturing standards and inspection; 503A brings patient-specific preparation under state oversight. What matters is that you can identify the pharmacy and check its record.

Sources

FDA: Human drug compounding — 503A and 503B (regulator)
FDA: Registered outsourcing facilities (regulator)
Drug Quality and Security Act of 2013 (statute)

Educational information, not medical advice. Decisions about GLP-1 medication belong with you and a licensed clinician who knows your history. Compounded medications are not FDA-approved. Report an error.